Figure 6. Sensitivity Analysis for Body Weight — Individual Agent Level Network Meta-analysis.

Figure 6Sensitivity Analysis for Body Weight — Individual Agent Level Network Meta-analysis

Δ = change; AG = alpha glucosidase; BL = baseline; CrI = credible interval; DPP-4 = dipeptidyl peptidase-4; GLP-1 = glucagon-like peptide-1; NA = not applicable; NMA = network meta-analysis; TZDs = thiazolidinediones.

Note: All active treatments and placebo were provided in combination with metformin.

From: APPENDIX 4, NETWORK META-ANALYSIS OF INDIVIDUAL AGENTS

Cover of Second-Line Pharmacotherapy for Type 2 Diabetes — Update
Second-Line Pharmacotherapy for Type 2 Diabetes — Update [Internet].
CADTH Optimal Use Report, No. 3.1A.
Copyright © CADTH 2013.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.